MedChem Express

MedChem Express logo

MedChemExpress has an experienced team of custom synthesis chemists, led by an impressive group of Ph.D.'s. With this team, we have the capability of supporting all kinds of chemistry projects of multiple step syntheses of complex labeled molecules, including metabolites and steroids. Following scientific and technological innovation, challenging traditional thinking, MedChemExpress has always been committed to develop quality products that exceed international standards on cost and reliability, to create the most advanced synthetic route. With high experiences in preparing a large numbers of different biologically active molecules, we provide rapid synthesis of new products. That is why we can consistently deliver your custom synthesis compounds faster than any other company.

Company Website

Product Listing

(-)-(S)-B-973B 10 mM * 1 mL  | 99.93%

MedChem Express

(-)-(S)-B-973B is a potent allosteric agonist and positive allosteric modulator of α7 nAChR, with antinociceptive activity[1].

More Information Supplier Page

(-)-(S)-B-973B 5 mg  | 99.93%

MedChem Express

(-)-(S)-B-973B is a potent allosteric agonist and positive allosteric modulator of α7 nAChR, with antinociceptive activity[1].

More Information Supplier Page

(-)-(S)-B-973B 10 mg  | 99.93%

MedChem Express

(-)-(S)-B-973B is a potent allosteric agonist and positive allosteric modulator of α7 nAChR, with antinociceptive activity[1].

More Information Supplier Page

(-)-(S)-B-973B 50 mg  | 99.93%

MedChem Express

(-)-(S)-B-973B is a potent allosteric agonist and positive allosteric modulator of α7 nAChR, with antinociceptive activity[1].

More Information Supplier Page

(-)-(S)-B-973B 100 mg  | 99.93%

MedChem Express

(-)-(S)-B-973B is a potent allosteric agonist and positive allosteric modulator of α7 nAChR, with antinociceptive activity[1].

More Information Supplier Page

(-)-(S)-Equol 5mg  | ≥98%

MedChem Express

(-)-(S)-Equol is a high affinity ligand for estrogen receptor β with a Ki of 0.73 nM. IC50 & Target: Ki: 0.73 nM (Estrogen receptor β)[1] In Vitro: (-)-(S)-Equol shows the greatest affinity for ERβ (Ki=0.73±0.2 nM), whereas its affinity for ERα (Ki=6.41±1 nM) is relatively poor[1]. (-)-(S)-Equol inhibits the growth of LnCaP, DU145 and PC3 […]

More Information Supplier Page

(-)-(S)-Equol 10mg  | ≥98%

MedChem Express

(-)-(S)-Equol is a high affinity ligand for estrogen receptor β with a Ki of 0.73 nM. IC50 & Target: Ki: 0.73 nM (Estrogen receptor β)[1] In Vitro: (-)-(S)-Equol shows the greatest affinity for ERβ (Ki=0.73±0.2 nM), whereas its affinity for ERα (Ki=6.41±1 nM) is relatively poor[1]. (-)-(S)-Equol inhibits the growth of LnCaP, DU145 and PC3 […]

More Information Supplier Page

(-)-(S)-Equol 25mg  | ≥98%

MedChem Express

(-)-(S)-Equol is a high affinity ligand for estrogen receptor β with a Ki of 0.73 nM. IC50 & Target: Ki: 0.73 nM (Estrogen receptor β)[1] In Vitro: (-)-(S)-Equol shows the greatest affinity for ERβ (Ki=0.73±0.2 nM), whereas its affinity for ERα (Ki=6.41±1 nM) is relatively poor[1]. (-)-(S)-Equol inhibits the growth of LnCaP, DU145 and PC3 […]

More Information Supplier Page

(-)-(S)-Equol 50mg  | ≥98%

MedChem Express

(-)-(S)-Equol is a high affinity ligand for estrogen receptor β with a Ki of 0.73 nM. IC50 & Target: Ki: 0.73 nM (Estrogen receptor β)[1] In Vitro: (-)-(S)-Equol shows the greatest affinity for ERβ (Ki=0.73±0.2 nM), whereas its affinity for ERα (Ki=6.41±1 nM) is relatively poor[1]. (-)-(S)-Equol inhibits the growth of LnCaP, DU145 and PC3 […]

More Information Supplier Page

(-)-(S)-Equol 10mM/1mL  | ≥98%

MedChem Express

(-)-(S)-Equol is a high affinity ligand for estrogen receptor β with a Ki of 0.73 nM. IC50 & Target: Ki: 0.73 nM (Estrogen receptor β)[1] In Vitro: (-)-(S)-Equol shows the greatest affinity for ERβ (Ki=0.73±0.2 nM), whereas its affinity for ERα (Ki=6.41±1 nM) is relatively poor[1]. (-)-(S)-Equol inhibits the growth of LnCaP, DU145 and PC3 […]

More Information Supplier Page

(-)-BAY-1251152 10 mM * 1 mL  | 99.82%

MedChem Express

(-)-BAY-1251152 is an enanthiomer of BAY-1251152 with rotation (-). BAY-1251152 is a potent and highly selective PTEF/CDK9 inhibitor.

More Information Supplier Page

(-)-BAY-1251152 2 mg  | 99.82%

MedChem Express

(-)-BAY-1251152 is an enanthiomer of BAY-1251152 with rotation (-). BAY-1251152 is a potent and highly selective PTEF/CDK9 inhibitor.

More Information Supplier Page

(-)-BAY-1251152 5 mg  | 99.82%

MedChem Express

(-)-BAY-1251152 is an enanthiomer of BAY-1251152 with rotation (-). BAY-1251152 is a potent and highly selective PTEF/CDK9 inhibitor.

More Information Supplier Page

(-)-BAY-1251152 10 mg  | 99.82%

MedChem Express

(-)-BAY-1251152 is an enanthiomer of BAY-1251152 with rotation (-). BAY-1251152 is a potent and highly selective PTEF/CDK9 inhibitor.

More Information Supplier Page

(-)-BAY-1251152 50 mg  | 99.82%

MedChem Express

(-)-BAY-1251152 is an enanthiomer of BAY-1251152 with rotation (-). BAY-1251152 is a potent and highly selective PTEF/CDK9 inhibitor.

More Information Supplier Page

(-)-BAY-1251152 2mg  | ≥98%

MedChem Express

(-)-BAY-1251152 is an enanthiomer of BAY-1251152 with rotation (-). BAY-1251152 is a potent and highly selective PTEF/CDK9 inhibitor.

More Information Supplier Page

(-)-BAY-1251152 5mg  | ≥98%

MedChem Express

(-)-BAY-1251152 is an enanthiomer of BAY-1251152 with rotation (-). BAY-1251152 is a potent and highly selective PTEF/CDK9 inhibitor.

More Information Supplier Page

(-)-BAY-1251152 50mg  | ≥98%

MedChem Express

(-)-BAY-1251152 is an enanthiomer of BAY-1251152 with rotation (-). BAY-1251152 is a potent and highly selective PTEF/CDK9 inhibitor.

More Information Supplier Page

(-)-BAY-1251152 10mg  | ≥98%

MedChem Express

(-)-BAY-1251152 is an enanthiomer of BAY-1251152 with rotation (-). BAY-1251152 is a potent and highly selective PTEF/CDK9 inhibitor.

More Information Supplier Page

(-)-BAY-1251152 10mM/1mL  | ≥98%

MedChem Express

(-)-BAY-1251152 is an enanthiomer of BAY-1251152 with rotation (-). BAY-1251152 is a potent and highly selective PTEF/CDK9 inhibitor.

More Information Supplier Page

(-)-Blebbistatin 10 mM * 1 mL  | 99.42%

MedChem Express

(-)-Blebbistatin is an S enantiomer of blebbistatin. Blebbistatin is a potent and selective myosin II inhibitor with IC50s ranging from 0.5 to 5 μM.

More Information Supplier Page

(-)-Blebbistatin 5 mg  | 99.42%

MedChem Express

(-)-Blebbistatin is an S enantiomer of blebbistatin. Blebbistatin is a potent and selective myosin II inhibitor with IC50s ranging from 0.5 to 5 μM.

More Information Supplier Page

(-)-Blebbistatin 10 mg  | 99.42%

MedChem Express

(-)-Blebbistatin is an S enantiomer of blebbistatin. Blebbistatin is a potent and selective myosin II inhibitor with IC50s ranging from 0.5 to 5 μM.

More Information Supplier Page

(-)-Blebbistatin 50 mg  | 99.42%

MedChem Express

(-)-Blebbistatin is an S enantiomer of blebbistatin. Blebbistatin is a potent and selective myosin II inhibitor with IC50s ranging from 0.5 to 5 μM.

More Information Supplier Page

(-)-Blebbistatin 5mg  | ≥98%

MedChem Express

(-)-Blebbistatin is an S enantiomer of blebbistatin. Blebbistatin is a potent and selective myosin II inhibitor with IC50 values ranging from 0.5 to 5 μM. IC50 & Target: IC50: 0.5 to 5 μM (myosin II)[1] In Vitro: Blebbistatin potently inhibits several striated muscle myosins as well as vertebrate nonmuscle myosin IIA and IIB with IC50 […]

More Information Supplier Page

(-)-Blebbistatin 10mg  | ≥98%

MedChem Express

(-)-Blebbistatin is an S enantiomer of blebbistatin. Blebbistatin is a potent and selective myosin II inhibitor with IC50 values ranging from 0.5 to 5 μM. IC50 & Target: IC50: 0.5 to 5 μM (myosin II)[1] In Vitro: Blebbistatin potently inhibits several striated muscle myosins as well as vertebrate nonmuscle myosin IIA and IIB with IC50 […]

More Information Supplier Page

(-)-Blebbistatin 50mg  | ≥98%

MedChem Express

(-)-Blebbistatin is an S enantiomer of blebbistatin. Blebbistatin is a potent and selective myosin II inhibitor with IC50 values ranging from 0.5 to 5 μM. IC50 & Target: IC50: 0.5 to 5 μM (myosin II)[1] In Vitro: Blebbistatin potently inhibits several striated muscle myosins as well as vertebrate nonmuscle myosin IIA and IIB with IC50 […]

More Information Supplier Page

(-)-Blebbistatin 10mM/1mL  | ≥98%

MedChem Express

(-)-Blebbistatin is an S enantiomer of blebbistatin. Blebbistatin is a potent and selective myosin II inhibitor with IC50 values ranging from 0.5 to 5 μM. IC50 & Target: IC50: 0.5 to 5 μM (myosin II)[1] In Vitro: Blebbistatin potently inhibits several striated muscle myosins as well as vertebrate nonmuscle myosin IIA and IIB with IC50 […]

More Information Supplier Page

(-)-Borneol 10mM/1mL  | ≥98%

MedChem Express

(-)-Borneol has a highly efficacious positive modulating action at GABA receptor with an EC50 of 237 μM. IC50 & Target: EC50: 237 μM (GABA receptor)[1] In Vitro: (-)-Borneol is an enantiomer of (+)-Borneol. (+)-Borneol is a natural bicyclic monoterpene used for analgesia and anesthesia in traditional Chinese medicine; enhances GABA receptor activity with an EC50 […]

More Information Supplier Page

(-)-Borneol 100mg  | ≥98%

MedChem Express

(-)-Borneol has a highly efficacious positive modulating action at GABA receptor with an EC50 of 237 μM. IC50 & Target: EC50: 237 μM (GABA receptor)[1] In Vitro: (-)-Borneol is an enantiomer of (+)-Borneol. (+)-Borneol is a natural bicyclic monoterpene used for analgesia and anesthesia in traditional Chinese medicine; enhances GABA receptor activity with an EC50 […]

More Information Supplier Page

(-)-Catechin gallate 5 mg  | 99.98%

MedChem Express

(-)-Catechin gallate is a minor constituent in green tea catechins. (-)-Catechin gallate inhibits the activity of COX-1 and COX-2 enzymes.

More Information Supplier Page

(-)-Catechin gallate 10 mg  | 99.98%

MedChem Express

(-)-Catechin gallate is a minor constituent in green tea catechins. (-)-Catechin gallate inhibits the activity of COX-1 and COX-2 enzymes.

More Information Supplier Page

(-)-Catechin gallate 5mg  | ≥98%

MedChem Express

(-)-Catechin gallate is a minor constituent in green tea catechins. (-)-Catechin gallate inhibits the activity of COX-1 and COX-2 enzymes. IC50 & Target: COX-1 and COX-2[1] In Vitro: (-)-Catechin gallate (CG) directly interacts with DNA oligomers and inhibits the activity of COX-1 and COX-2 enzymes, the gene expression of matrix metalloproteinase-9 in macrophage-differentiated HL-60 myeloid […]

More Information Supplier Page

(-)-Catechin gallate 10mg  | ≥98%

MedChem Express

(-)-Catechin gallate is a minor constituent in green tea catechins. (-)-Catechin gallate inhibits the activity of COX-1 and COX-2 enzymes. IC50 & Target: COX-1 and COX-2[1] In Vitro: (-)-Catechin gallate (CG) directly interacts with DNA oligomers and inhibits the activity of COX-1 and COX-2 enzymes, the gene expression of matrix metalloproteinase-9 in macrophage-differentiated HL-60 myeloid […]

More Information Supplier Page

(-)-Catechin gallate 10mM/1mL  | ≥98%

MedChem Express

(-)-Catechin gallate is a minor constituent in green tea catechins. (-)-Catechin gallate inhibits the activity of COX-1 and COX-2 enzymes. IC50 & Target: COX-1 and COX-2[1] In Vitro: (-)-Catechin gallate (CG) directly interacts with DNA oligomers and inhibits the activity of COX-1 and COX-2 enzymes, the gene expression of matrix metalloproteinase-9 in macrophage-differentiated HL-60 myeloid […]

More Information Supplier Page

(-)-Cephaeline (dihydrochloride) 2mg  | ≥98%

MedChem Express

(-)-Cephaeline dihydrochloride is an enantiomer of Cephaeline dihydrochloride. Cephaeline dihydrochloride is a selective CYP2D6 inhibtor with IC50 of 121 μM. IC50 & Target: IC50: 121 μM (CYP2D6)[1] Ki: 54 μM (CYP2D6)[1] In Vitro: CYP2D6 reveals the highest metabolic activity for the generation of 9-O-demethylEmetine, whereas this enzyme also shows a significant metabolic activity for the […]

More Information Supplier Page

(-)-Cephaeline (dihydrochloride) 5mg  | ≥98%

MedChem Express

(-)-Cephaeline dihydrochloride is an enantiomer of Cephaeline dihydrochloride. Cephaeline dihydrochloride is a selective CYP2D6 inhibtor with IC50 of 121 μM. IC50 & Target: IC50: 121 μM (CYP2D6)[1] Ki: 54 μM (CYP2D6)[1] In Vitro: CYP2D6 reveals the highest metabolic activity for the generation of 9-O-demethylEmetine, whereas this enzyme also shows a significant metabolic activity for the […]

More Information Supplier Page

(-)-Cevimeline (hydrochloride hemihydrate) 1mg  | ≥98%

MedChem Express

Cevimeline hydrochloride hemihydrate, a novel muscarinic receptor agonist, is a candidate therapeutic drug for xerostomia in Sjogren’s syndrome. IC50 value: Target: mAChR The general pharmacol. properties of this drug on the gastrointestinal, urinary, and reproductive systems and other tissues were investigated in mice, rats, guinea pigs, rabbits, and dogs. The in vitro metab. of SNI-2011 […]

More Information Supplier Page

(-)-Cevimeline (hydrochloride hemihydrate) 5mg  | ≥98%

MedChem Express

Cevimeline hydrochloride hemihydrate, a novel muscarinic receptor agonist, is a candidate therapeutic drug for xerostomia in Sjogren’s syndrome. IC50 value: Target: mAChR The general pharmacol. properties of this drug on the gastrointestinal, urinary, and reproductive systems and other tissues were investigated in mice, rats, guinea pigs, rabbits, and dogs. The in vitro metab. of SNI-2011 […]

More Information Supplier Page

(-)-Cevimeline (hydrochloride hemihydrate) 10mM/1mL  | ≥98%

MedChem Express

Cevimeline hydrochloride hemihydrate, a novel muscarinic receptor agonist, is a candidate therapeutic drug for xerostomia in Sjogren’s syndrome. IC50 value: Target: mAChR The general pharmacol. properties of this drug on the gastrointestinal, urinary, and reproductive systems and other tissues were investigated in mice, rats, guinea pigs, rabbits, and dogs. The in vitro metab. of SNI-2011 […]

More Information Supplier Page